
[ Thu, Oct 21st 2021 ]: WOPRAI
[ Thu, Oct 21st 2021 ]: WOPRAI
[ Thu, Oct 21st 2021 ]: WOPRAI

[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI
[ Wed, Oct 20th 2021 ]: WOPRAI

[ Tue, Oct 19th 2021 ]: WOPRAI
[ Tue, Oct 19th 2021 ]: WOPRAI
[ Tue, Oct 19th 2021 ]: WOPRAI
Tazeen Ahmad Downgraded (ASND) to Hold and Increased Target to $169 on, Oct 20th, 2021


🞛 This publication is a summary or evaluation of another publication
Tazeen Ahmad of B of A Securities, Downgraded "Ascendis Pharma A/S" (ASND) to Hold and Increased Target from $164 to $169 on, Oct 20th, 2021.
Tazeen has made no other calls on ASND in the last 4 months.
There are 3 other peers that have a rating on ASND. Out of the 3 peers that are also analyzing ASND, 0 agree with Tazeen's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Tazeen
- David Lebowitz of "Morgan Stanley" Maintained at Buy with Increased Target to $204 on, Thursday, August 26th, 2021
- Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $182 on, Thursday, August 26th, 2021
- Tiago Fauth of "Credit Suisse" Maintained at Buy with Increased Target to $185 on, Thursday, August 26th, 2021